Back to Search
Start Over
Omnipharm declared the winner in Frontline patent battle.
- Source :
- Managing Intellectual Property; Jan2013, Issue 227, p36-36, 1p
- Publication Year :
- 2013
-
Abstract
- The article focuses on an appeal by animal health company Merial concerning one of its patents being declared invalid for insufficiency. It states that the in 2010 bulk all natural ingredient supplier Omnipharm asked the British High Court to revoke two key patents covering Merial's Frontline products and mentions the High Court revoked one of the patents and ordered Merial to pay 40 percent of Omnipharm's costs. It mentions the lower court's ruling was upheld by the British Court of Appeal.
- Subjects :
- PATENT invalidation
PATENT suits
ACTIONS & defenses (Law)
Subjects
Details
- Language :
- English
- ISSN :
- 09605002
- Issue :
- 227
- Database :
- Complementary Index
- Journal :
- Managing Intellectual Property
- Publication Type :
- Periodical
- Accession number :
- 85588682